Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(67)
Hiroyoshi Iwata
4
Shigeaki Ohno (大野重昭)
3
K. Tamura
3
Satoru Noguchi
3
Hirotaka Iwase
3
Journals
(5)
Breast
3
EJC SUPPL
2
ANN ONCOL
1
BRIT J CANCER
1
Water Nepal
1
Keywords
(22)
Embed
Subscribe
Academic
Authors
Y. Rai
Y. Rai,Kagoshima University,Oncology,Anatomy,Ecology
Edit
Y. Rai
Kagoshima University
Publications:
8
|
Citations:
12
Fields:
Oncology
,
Anatomy
,
Ecology
View FAQ about top research areas and Fields of study
Collaborated with
67 co-authors
from 2004 to 2011
|
Cited by
72 authors
Cumulative
Annual
Sort by:
Publications
(8)
BibTeX
|
RIS
|
RefWorks
Download
P278 Feasibility study of adjuvant fluorouracil/epirubicin/cyclophosphamide (FEC 100) followed by triweekly docetaxel (D) plus trastuzumab (H) in HER2/neu positive early breast cancer
M. Tanaka
,
K. Anan
,
S. Umeda
,
M. Yamaguchi
,
H. Sasaki
,
Y. Rai
,
S. Ohno
,
U. Toh
,
K. Tamura
,
S. Mitsuyama
Journal:
Breast
, vol. 20, pp. S66-S67, 2011
Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1)
(
Citations: 2
)
S. Ohno
,
Y. Rai
,
H. Iwata
,
N. Yamamoto
,
M. Yoshida
,
H. Iwase
,
N. Masuda
,
S. Nakamura
,
H. Taniguchi
,
S. Kamigaki
,
S. Noguchi
Journal:
Annals of Oncology - ANN ONCOL
, vol. 21, no. 7, 2010
415 Comparison of two Phase II trials evaluating three dosing regimens of fulvestrant in Japanese vs non-Japanese postmenopausal women with advanced breast cancer (FINDER1 and FINDER2)
H. Iwata
,
S. Ohno
,
Y. Rai
,
N. Yamamoto
,
M. Yoshida
,
H. Iwase
,
J. Lindemann
,
M. Macpherson
,
S. Noguchi
,
K. I. Pritchard
Journal:
Ejc Supplements - EJC SUPPL
, vol. 8, no. 3, pp. 178-178, 2010
459 Monthly versus three-monthly goserelin treatment in premenopausal patients with oestrogen receptor-positive early breast cancer
Y. Rai
,
H. Iwata
,
N. Masuda
,
K. Anan
,
T. Takeuchi
,
N. Kohno
,
H. Takei
,
Y. Yanagita
,
S. Noguchi
Journal:
Ejc Supplements - EJC SUPPL
, vol. 8, no. 3, pp. 193-193, 2010
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
(
Citations: 10
)
M Toi
,
H Iwata
,
Y Fujiwara
,
Y Ito
,
S Nakamura
,
Y Tokuda
,
T Taguchi
,
Y Rai
,
K Aogi
,
T Arai
,
J Watanabe
,
T Wakamatsu
http://academic.research.microsoft.com/io.ashx?type=5&id=28850417&selfId1=54028405&selfId2=0&maxNumber=12&query=
Journal:
British Journal of Cancer - BRIT J CANCER
, vol. 101, no. 10, pp. 1676-1682, 2009
Sort by:
Citations
(12 times by 12 publications)
PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib
(
Citations: 1
)
Leiping Wang
,
Qunling Zhang
,
Jian Zhang
,
Si Sun
,
Haiyi Guo
,
Zhen Jia
,
Biyun Wang
,
Zhimin Shao
,
Zhonghua Wang
,
Xichun Hu
Journal:
BMC Cancer
, vol. 11, no. 1, pp. 1-10, 2011
High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer
Jiyoung Rhee
,
Sae-Won Han
,
Yongjun Cha
,
Hye Seon Ham
,
Hwang-phill Kim
,
Do-Youn Oh
,
Seock-Ah Im
,
Jong-Wan Park
,
Jungsil Ro
,
Keun Seok Lee
,
In Hae Park
,
Young-Hyuck Im
http://academic.research.microsoft.com/io.ashx?type=5&id=48282586&selfId1=54028405&selfId2=0&maxNumber=12&query=
Journal:
Breast Cancer Research and Treatment - BREAST CANCER RES TREAT
, vol. 125, no. 1, pp. 107-114, 2011
Trastuzumab et lapatinib dans la prise en charge du cancer du sein HER2 positif
S. Guiu
,
I. Adoubi
,
J. C. Kouassi Comoe
,
P. Fumoleau
,
B. Coudert
Journal:
Journal Africain Du Cancer / African Journal of Cancer
, vol. 3, no. 2, pp. 128-140, 2011
Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification
J Tanizaki
,
I Okamoto
,
S Fumita
,
W Okamoto
,
K Nishio
,
K Nakagawa
Journal:
Oncogene
, vol. 30, no. 39, pp. 4097-4106, 2011
Management of Aromatase Inhibitor-Resistant Disease with Estrogen, Selective Estrogen Receptor Down-Regulators, and Other Agents
Catherine Oakman
,
Libero Santarpia
,
Erica Moretti
,
Laura Biganzoli
,
Angelo Di Leo
Journal:
Current Breast Cancer Reports
, vol. 3, no. 1, pp. 24-33, 2011
Comments